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ABSTRACT T-cell precursors were stimulated with a
conventional T-cell mitogen or with the calcium ionophore
A23187 in order to determine whether pre-T cells acquire the
ability to produce interleukin 2 (IL-2) before they acquire the
ability to respond to antigen or mitogenic lectins. Immature T
cells were obtained by eliminating mouse thymocytes that
expressed the Lyt2 and L3T4 cell surface proteins. The
remaining Lyt2-,L3T4- cells were stimulated for IL-2 pro-
duction by using concanavalin A (Con A) or A23187, together
with phorbol 12-myristate 13-acetate (PMA). We found that
these "double-negative" thymocytes were unresponsive to Con
A plus PMA but produced substantial amounts of IL-2 when
stimulated with A23187 plus PMA. In contrast, both stimula-
tion regimens induced more mature T-lymphocyte populations
to produce IL-2. This implies that developing T cells acquire
the ability to make IL-2 upon induction before they acquire the
ability to be triggered by Con A. Day-15 fetal and cortical
thymocytes were also tested for their ability to make IL-2. Both
populations failed to synthesize this growth factor, even when
stimulated with A23187 and PMA. For cortical thymocytes,
this result, together with the finding that A23187 plus PMA
fails to activate these cells, suggests that this population is
immunologically inert rather than immature. On the other
hand, the inability of day-15 fetal thymocytes to produce IL-2
indicates that these T-cell precursors are developmentally
distinct from adult Lyt2-,L3T4- thymocytes, which they
phenotypically resemble.
Intrathymic T-cell ontogeny is a complex process that is not
well understood. During their development, immature T cells
rearrange gene segments that code for the variable portion of
the a, ,B, and y chains of the T-cell antigen receptor (1-3),
develop the capacity to transduce antigen binding into a
mitogenic signal (4), and begin to express cell surface
molecules that will allow them to interact with each other and
with nonlymphoid components of the immune system (5).
This maturation process involves the activation of genes that
appear to be expressed constitutively by mature T cells and
the activation of genes whose transcription is antigen-
induced. Some constitutively expressed gene products are
cell surface glycoproteins (for example, Lyt2, L3T4, and TL)
that become permanent lineage markers (reviewed in ref. 6).
Activation of inducible genes, such as those whose products
help mediate immune responsiveness, is more difficult to
assess, since it involves both the acquired ability of the gene
to be transcribed in response to inducer and the ability of the
cell to convert the external inductive stimulus into an internal
one. Therefore, to determine the developmental stage at
which these genes can first be transcribed, their status must
be assessed as independently as possible of the membrane
receptors involved with antigen recognition and of the
intracellular proteins that transmit signals from these mole-
cules to the nucleus.
One way to determine whether particular genes are induc-
ible in immature T cells is to bypass the antigen receptor by
mimicking the signals it would normally deliver. Within
minutes of exposure to antigen or a lectin like Con A, T cells
show two signs of stimulation: their concentration of intra-
cellular free calcium ([Ca2+],) increases, and protein kinase C
is activated (7, 8). These changes appear to be involved in
signal transduction, since mature T cells can also be stimu-
lated by agents that effect these changes directly. When their
[Ca2+], is raised by treatment with the calcium ionophore
A23187, and when the tumor promoter phorbol 12-myristate
13-acetate (PMA) is used to activate their protein kinase C,
mature T cells and cloned T-cell lines are induced to divide
and to produce the T-cell growth factor interleukin 2 (IL-2) (9,
10). Because their activity is independent of the T-cell antigen
receptor, these reagents may activate mature T cells and their
thymic precursors equally well. For these reasons, we used
stimulation with A23187 and PMA to determine whether
Lyt2-, L3T4- thymocytes, which include the most immature
pre-T cells in the adult thymus (11, 12), are able to activate
the inducible gene encoding IL-2. Here we report that these
"double-negative" thymocytes produce IL-2 after stimula-
tion with the ionophore plus PMA but fail to do so upon
stimulation with Con A plus PMA. We also show that day-15
fetal thymocytes and dividing lymphoblasts of the major
cortical lineage fail to produce IL-2 in vitro regardless of the
stimulation conditions used. Therefore, the ability to secrete
IL-2 is not a universal attribute of T-cell precursors.
MATERIALS AND METHODS
Animals. C57BL/6 (B6) mice were bred and maintained in
the animal facility at the California Institute of Technology.
Young adult mice were 4-6 weeks old. For timed pregnan-
cies, breeding quartets were caged overnight and the females
were checked for vaginal plugs the next day. The day of
vaginal-plug detection was designated day 0.
Reagents. The calcium ionophore A23187 (Sigma) was
stored as a 1 mg/ml stock in dimethyl sulfoxide at -20°C. The
tumor promoterPMA (Sigma) was stored as a 10 ,ug/ml stock
in 95% ethanol. Complement lysis medium consisted of a 1:30
final dilution of baby rabbit complement (Pel-Freez) and 100
,ug of DNase I (Sigma) per ml in 0.25% bovine serum
albumin/RPMI 1640 medium (BSA/RPMI). Bovine serum
albumin stocks (30%, wt/vol) were purchased from Irvine
Scientific.
Monoclonal Antibodies (mAbs) and Flow Microfluorometry.
AD4.15 is a mouse IgM mAb specific for Lyt2.2 (13). Ascites
from the corresponding hybridoma was produced in (B6 x
BALB/c)F1 females. GK1.5, a rat IgG mAb specific for the
Abbreviations: [Ca2W]j, intracellular calcium; IL-2, interleukin 2;
mAb, monoclonal antibody; PnA, peanut agglutinin; PMA, phorbol
12-myristate 13-acetate.
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L3T4 molecule (14), and Mar 18.5, a mouse IgG2a mAb
specific for rat K chains (15), were used as culture superna-
tants. The latter hybridoma was generously provided by K.
Wall (University of Texas Health Science Center, San
Antonio, TX). Monoclonal anti-Lytl.2 (CG-16) and anti-Thy-
1.2 (13-4) ascites were purchased from Accurate Chemical,
(Westbury, NY) and New England Nuclear, respectively.
The rat IgM mAb 7D4, which detects the mouse IL-2 receptor
(16), was used as a culture supernatant. Flow microfluorom-
etry was done as described (17).
Preparation of Thymocyte Subpopulations. Double-neg-
ative thymocytes were obtained by sequentially eliminating
Lyt2' and L3T4' cells. Unfractionated thymocytes (5 x 107
cells per ml) were incubated for 45 min on ice in BSA/RPMI
containing AD4.15 ascitic fluid (1:100 final dilution), washed,
and then resuspended in complement lysis medium to 3-5 x
107 cells per ml. After 45 min of incubation at 370C, viable
cells (15% initial input) were separated from dead cells by
flotation centrifugation (15 min; 1500 x g) through a 15/30o
discontinuous bovine serum albumin gradient at 40C. Sixty-
five to seventy-five percent of the live cells were recovered,
with viabilities >98%. These Lyt2- cells were then incubated
for 45 min on ice in undiluted GK1.5 culture supernatant,
then washed into Marl8.5 culture supernatant (3-5 x 107
cells per ml) and placed on ice for 20 min, prior to treatment
with complement. Eighty-five to ninety percent of the viable
cells (:21% initial input) were recovered after flotation
centrifugation. Further treatment of these cells to remove
Lyl+ or IL-2 receptor-positive cells was done as described
for the AD4.15 elimination step, using CG-16 ascites at 1:100
dilution and 7D4 as an undiluted culture supernatant. The
fractionation of thymocytes according to both size and
peanut agglutinin (PnA)-binding ability has been described
(17, 18). PnA+ blasts here represent the 50% of cells in the
cycling population that bound most tightly to PnA-coated
plates.
Production and Assay of IL-2. IL-2 induction cultures
consisted of 3-5 x 106 cells per ml in RPMI 1640 supple-
mented with 10% fetal bovine serum, nonessential amino
acids, 1 mM sodium pyruvate, 50 ,uM 2-mercaptoethanol, 2
mM L-glutamine, penicillin (100 units/ml), and streptomycin
(100 pug/ml). Cells were stimulated with Con A or A23187,
with or without PMA (17 nM), as indicated. Cultures were
harvested after 20-24 hr of stimulation unless otherwise
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cloned T-cell line MTL 2.8.2 (18). IL-2 activity units are the
reciprocal of the dilution that yielded 30% maximal incorpo-
ration of 5-['251]iododeoxyuridine.
RESULTS
Double-Negative Thymocytes Produce IL-2. Thymic lym-
phocytes are divisible into four populations based on their
Lyt2 and L3T4 phenotypes (11, 12). One of these popula-
tions, the Lyt2-,L3T4- (double-negative) thymocytes, con-
tains within it cells capable of repopulating irradiated thymus
glands and generating all the other T-cell populations nor-
mally found in this organ (11). To examine IL-2 expression
during early T-cell ontogeny, we isolated these precursors by
eliminating all Lyt2+ and L3T4+ thymocytes by lysis with
antibodies and complement. Flow cytometry was used to
assess how well our elimination procedure worked. As shown
in Fig. 1, we could not detect any Lyt2+ or L3T4+ cells over
background staining. Most (85-90%) double-negative
thymocytes were lymphoid, because they stained as brightly
for Thy-i as did unfractionated thymocytes (Fig. 1 A and E).
Unlike thymocytes overall, however, a large fraction
(50-60%) of double-negative thymocytes stained with mAb
7D4 (Fig. 1 D and H), suggesting that these cells express
receptors for IL-2. This finding was consistent with reports
from other groups (19-21).
As shown in Table 1, double-negative cells produced
significant amounts of IL-2 in response to A23187 plus PMA
but did not do so when stimulated with Con A plus PMA. The
failure of Con A plus PMA to elicit IL-2 from these cells was
not due to suboptimal stimulation conditions. Various con-
centrations of Con A, from 0.75 to 24 jg/ml, failed to induce
these cells to make IL-2 (Fig. 2D and data not shown), nor did
decreasing or increasing the time of exposure to Con A result
in IL-2 synthesis (Fig. 3A). Moreover, the similar IL-2
production profiles of spleen cells, unfractionated thymo-
cytes, and double-negative pre-T cells measured in response
to various doses of A23187 suggested that the IL-2 producers
in each of these cell populations have similar activation
requirements (Fig. 2 A, B, and D). Finally, the inability of
Con A to elicit IL-2 from double-negative thymocytes was
not due to a lack of expression of Con A binding sites by the
cells: double-negative cells and spleen cells were agglutinated
equally well by Con A (data not shown). However, it is






FIG. 1. Flow cytometric analysis of unfractionated and double-negative (Dbl Neg) thymocytes. Unfractionated (A-D) and double negative
(E-H) thymocytes were incubated with saturating amounts of mAbs specific for the indicated cell surface proteins and then were stained with
fluorescein isothiocyanate-conjugated goat anti-rat or anti-mouse IgG (-). In each case, the negative control was cells stained with the
second-stage reagent alone ( ). Each histogram represents the signals from 20,000 cells, gated to exclude aggregates and debris by the correlated
intensity of forward light scatter (not shown). The arrow in each panel indicates the threshold of positive staining (""5% background "positive"
cells) with second antibody. By this criterion, 50% of double-negative thymocytes stained with anti-IL-2-receptor mAb, whereas only 2-3%
stained with anti-L3T4 or anti-Lyt2 mAb.
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Stimulation Total* T-depletedt Unfrac Dbl Neg D15
Con A 35 ± 15 <1 <1 <1 <1
Con A + PMA 218 ± 18 1 18 ± 2 <1 <1
A23187 <1 <1 <1 <1 <1
A23187 + PMA 702 ± 50 5 80 ± 3 103 ± 43 <1
Spleen cells and unfractionated thymoctyes were stimulated at 5 x
106 cells per ml; double-negative (Dbl Neg) and day-15 (D15) fetal
thymocytes, at 3 x 106 cells/ml. Results are not normalized for cell
number. Final concentrations for the various activating agents: Con
A, 6 ,ug/ml; A23187, 0.48 A&M; PMA, 17 nM.
*Mean ± SEM of two experiments.
tT cells were removed by a one-step complement procedure using
the mAbs 13-4, GK1.5, and AD4.15. Results from one experiment.
*Mean ± SEM of three experiments.
those Con A-binding molecules that can transduce lectin
binding into an inductive stimulus.
Since -50% of the double-negative cells express IL-2
receptors (Fig. 1H), adsorption of IL-2 to receptor-bearing
cells could have interfered with our measurements of IL-2
production, especially if Con A were to augment IL-2
receptor expression. To investigate this possibility, IL2-
receptor-bearing cells were eliminated from double-negative
thymocyte preparations, and the remaining cells were tested
for IL-2 synthesis. The data presented in Table 2 show that
double-negative cells that lack IL-2 receptors can produce
IL-2, but only in response to ionophore and phorbol ester.
Since these cells do not appear to be enriched for IL-2
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FIG. 2. IL-2 production by various T-cell populations in response
to A23187 and Con A. Unfractionated thymocytes (A) and spleen
cells (B) were cultured at 5 x 106 cells per ml in IL-2-induction
medium containing the indicated amounts of A23187 (o) or Con A (o)
plus 17 nM PMA. After a 24-hr incubation period, culture superna-
tants were harvested and assayed for IL-2 as described in Materials
and Methods. Day-15 fetal (C) and adult double-negative (D)












FIG. 3. Kinetic analysis of IL-2 synthesis by various thymocyte
populations. Cells were stimulated with A23187 (0.48 AM, solid
symbols) or Con A (6 ,ug/ml, open symbols) along with 17 nM PMA
for the indicated periods of time. Supernatants were then harvested
and assayed for IL-2. (A) Day-15 fetal (o, *) and adult double-
negative (A, A) thymocytes. (B) PnA- (o, e) and PnA+ (A, *) thymic
lymphoblasts.
all, it is likely that IL-2 producers may also be found in the
IL-2-receptor-bearing class of double-negative cells.
In contrast to double-negative cells, unifractionated thymic
lymphocytes and spleen cells produced readily detectable
amounts of IL-2 when stimulated by Con A or A23187 plus
PMA (Table 1 and Fig. 2 A and B). The lower titers of IL-2
secreted by thymocytes reflect the lower frequency of IL-2
producers in the thymus (refs. 4, 18, and 22; also see below).
For each of these cell populations, A23187 plus PMA gen-
erally elicited 3- to 4-fold more IL-2 than did Con A plus
PMA. This ratio appeared characteristic ofmature T cells and
at no point exceeded 8-fold (see Table 3). The basis for this
effect is not known; however, it may in part be due to A23187
mediating a greater and perhaps longer-lasting increase in
[Ca2+i than the transient increase elicited by Con A (23).
Neither A23187 nor PMA alone effectively induced IL-2
biosynthesis in any population tested here (Table 1 and data
not shown). Con A alone, however, induced spleen cells to
make small amounts of IL-2, most likely because contami-
nating splenic accessory cells provide a "second signal" that
facilitates IL-2 production (24).
A23187 and PMA do not induce IL-2 biosynthesis from all
lymphocytes. T-cell-depleted splenic lymphocytes failed to
make IL-2 under any stimulation conditions (Table 1). Fur-
ther, of several T-cell hybridomas and cloned T-cell lines
tested for IL-2 synthesis, only those previously shown to
produce IL-2 in response to the appropriate antigen or Con
A made IL-2 after treatment with A23187 plus PMA (data not
shown). Thus, adult double-negative thymocytes represent a




Treatment* -PMA +PMA -PMA +PMA
None <1 <1 <1 110 ± 15
Complement <1 <1 <1 140 ± 20
Anti-IL-2 receptor
plus complement <1 <1 <1 70 ± 10
Anti-Lyl plus
complement <1 <1 <1 60 ± 20
Stimulations were carried out at 3 x 106 viable cells per ml, using
the tissue culture conditions described for Table 1. Results represent
mean ± SEM of three experiments.
*Fifty percent of the cells were killed with monoclonal anti-IL-2
receptor antibody (7D4) plus complement and 30% with monoclonal
anti-Lyl (CG-16) plus complement.
A B
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developing pre-T-cell population that contains committed
IL-2 producers that are not yet Con A-responsive.
Fetal Double-Negative Thymocytes Do Not Produce IL-2.
Recent studies have shown that day-15 fetal and adult
double-negative thymocytes resemble each other in several
ways. Both populations are enriched for precursors that can
give rise to all the other T-cell populations in the thymus (11,
25, 26). In addition, both types of cells lack detectable
expression of Lyt2 or L3T4 and contain mRNA for the y and
/3 chains of the T-cell antigen receptor but few or no a-chain
transcripts (2, 27-29). Further, 50-60% of the cells in each of
these populations express IL-2 receptors (refs. 19-21 and
unpublished data). These similarities prompted us to test
day-15 fetal thymocytes for IL-2 production. As shown in
Table 1 and Fig. 2C, these cells do not produce IL-2 under
any of our in vitro stimulation conditions, including stimu-
lation for up to 3 days with A23187 and PMA (Fig. 3A), even
though the fetal thymocytes remain viable and lymphoblas-
toid throughout the culture period. The inability to make IL-2
distinguishes these cells not only from adult double-negative
cells overall, but even from the adult subpopulation enriched
for precursors that resemble fetal thymocytes by expressing
low levels of Lyl (11). As shown in Table 2, adult double-
negative populations depleted of "Lyl-high" cells still pro-
duced readily detectable amounts of IL-2. These results
demonstrate that day-15 fetal and "Lyl-low" adult double-
negative thymocytes are not identical sets of cells.
Only PnA- Thymic Lymphoblasts Produce IL-2 in Response
to A23187 and PMA. T-cell precursors differentiate along at
least two developmental pathways. One lineage leads to the
appearance of small, PnA-binding (PnA+) cortical
thymocytes. These cells die intrathymically and exhibit little
or no responsiveness to either Con A or alloantigens (22, 30).
The other lineage is characterized by the formation of
immunocompetent T lymphocytes that bind PnA weakly
(PnA-). To determine whether lymphoblasts committed to
the cortical lineage (large PnA+ cells) or their nondividing
offspring (small PnA+ cells) make IL-2 in response to A23187
and PMA, thymocytes were fractionated according to their
size and their PnA-binding ability and then were stimulated
with these activators. The results are shown in Table 3. In
agreement with previous results (18), PnA- thymic
lymphoblasts produced IL-2 whether stimulated with Con A
or A23187 and PMA. However, neither lymphoblasts nor
postmitotic cells of the PnA+ class could be induced to make
IL-2. The small amount of IL-2 that dividing PnA+ cells
produced in some experiments is most likely due to PnA- cell
contamination. Varying the incubation periods or concentra-
tions of A23187 and Con A did not lead to higher IL-2 outputs
from PnA+ cells, when compared with their PnA- counter-
parts (Fig. 3B and Fig. 4A and B). Thus, cortical thymocytes,
including proliferating cortical blasts, do not appear to be
inducible for IL-2 expression. This characteristic sets these
cells apart both from PnA- "medullary" cells and from
Table 3. IL-2 production by fractionated thymocytes
IL-2 activity, units/ml
Con A A23187
Fraction -PMA +PMA -PMA +PMA
Small cells
PnA- <1 10 ± 3 <1 75 9
PnA' <1 <1 <1 <1
Large cells
PnA- 12 ± 10 140 ± 20 <1 520 ± 120
PnA' <1 6 ± 5 <1 30 ± 28
Stimulations were carried out at 5 x 106 cells per ml, using the
tissue culture conditions described for Table 1. Results represent the
mean + SEM of two (small cells) or three (large cells) experiments.
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FIG. 4. IL-2 production by PnA- and PnA+ thymic lymphoblasts
in response to various concentrations of A23187 and Con A. PnA-
(A) and PnA+ (B) large thymocytes were prepared by centrifugal
elutriation followed by PnA fractionation using PnA-coated dishes
(17, 18). Stimulations were done at 5 x 106 cells per ml in
IL-2-induction medium containing the indicated amounts of A23187
(o) or Con A (o) plus 17 nM PMA. After a 24-hr incubation period,
culture supernatants were harvested and assayed for IL-2.
double-negative thymocytes, some of which can differentiate
in culture into cortical cells (25, 26). Therefore, cortical
(PnA+) cells overall seem not so much to be "immature" as
to be the mature products of a developmental process that
leads to death instead of clonal expansion. In accord with this
possibility, we have found (unpublished data) that PnA+ blast
cells also fail to proliferate in response to IL-2 when treated
with A23187 and PMA, in contrast to double-negative
thymocytes or mature T cells.
DISCUSSION
The results presented here demonstrate that production of
IL-2 is inducible in immature thymocytes that are not yet Con
A-responsive; i.e., that responses associated with mature T
cells can be elicited from phenotypically immature precursor
cells. The double-negative population studied here includes
few if any cells that express the mature T-cell receptor for
antigen, since this population is strikingly deficient in mRNA
for the a chain of the antigen-binding receptor (2, 27). Any
antigen-binding structures that exist on these cells could be
comprised of y and /3 chains, rather than the al3 heterodimers
that are documented to bind antigen on mature T cells (31,
32). With mature T cells, ConA may act as a proxy for antigen
by binding to the T-cell antigen receptor complex. Engage-
ment of this complex triggers an increase in [Ca2+]1, which is
a major controlling factor for IL-2 secretion (33). The lack of
a chains in these cells and the probable lack of glycosylation
of y chains (34, 35) may account for the inability of Con A to
stimulate double-negative thymocytes. Nevertheless, cells in
the double-negative population are clearly competent to
secrete IL-2, provided that the increase in [Ca2+], which
activates the IL-2 gene is induced by a calcium ionophore.
Thus, stimulation with Con A fails to reveal the degree to
which these early precursors may already be programmed for
function.
Inducibility of the IL-2 gene appears to mark an interme-
diate stage, perhaps restricted to a specific lineage, in the
differentiation of immature thymocytes. Day-15 fetal
thymocytes resemble adult double-negative cells in many
ways, lacking Lyt2 and L3T4, but expressing Thy-1, IL-2
receptors, and mRNA for the y and 8 chains of the T-cell
receptor for antigen (20, 27-29). However, they do not make
IL-2, even when stimulated with A23187 and PMA. Yet, by
day 16, an IL-2 response is clearly detectable (data not
Immunology: Lugo et al.
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shown). These bulk-population data suggest that IL-2 induc-
ibility begins after rearrangement ofthe y- and /-chain genes,
but before the a-chain gene is expressed. Thus, the adult
double-negative cells may include an additional subpopula-
tion, more mature than day-15-type double-negative cells. To
identify the precise stage at which the IL-2 gene becomes
inducible, however, it will be necessary to make a critical
assessment of the heterogeneity in both the adult and fetal
double-negative populations. It is not yet certain whether the
IL-2-secreting cells represent the majority of adult double-
negative thymocytes or an atypical minority.
Although the lack of IL-2 production by fetal thymocytes
could be attributed to immaturity, we have found evidence
that thymocytes of the major cortical lineage may also be
blocked from carrying out this response. Both cortical
lymphoblasts and postmitotic cells fail to make IL-2 even
when stimulated with A23187 and PMA, suggesting a lesion
in some intracellular component of this inductive response
pathway. This explains the failure of cortical (PnA') cells to
be activated by Con A (18, 30) in spite of their expression of
apparently "mature" T-cell receptors for antigen (36). These
cells may develop from a lineage of double-negative cells that
never acquire the ability to make IL-2 or that lose this ability
with further differentiation.
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